Cover Image
市場調查報告書

腫瘤標記(癌症篩檢)免疫檢測市場 (PSA、CEA、CA 125、AFP、CA 15-3、CA 19-9、CYFRA 21-1、ProGRP、SCC、CA 72-4、HE4)

Tumor Markers Immunoassay Market (PSA, CEA, CA 125, AFP, CA 15-3, CA 19-9, CYFRA 21-1, ProGRP, SCC, CA 72-4, HE4, Others)

出版商 Kalorama Information 商品編碼 599535
出版日期 內容資訊 英文 144 Pages
訂單完成後即時交付
價格
Back to Top
腫瘤標記(癌症篩檢)免疫檢測市場 (PSA、CEA、CA 125、AFP、CA 15-3、CA 19-9、CYFRA 21-1、ProGRP、SCC、CA 72-4、HE4) Tumor Markers Immunoassay Market (PSA, CEA, CA 125, AFP, CA 15-3, CA 19-9, CYFRA 21-1, ProGRP, SCC, CA 72-4, HE4, Others)
出版日期: 2018年01月08日 內容資訊: 英文 144 Pages
簡介

本報告提供全球腫瘤標記(癌症篩檢)免疫檢測市場相關調查,標記、各地區的市場分析,與主要的腫瘤標記(癌症篩檢)免疫檢測特徵 (癌症的種類,分析組織,使用法),及主要企業等系統性資訊。

第1章 摘要整理

第2章 腫瘤標記(癌症篩檢)免疫檢測市場:分析

  • 腫瘤標記(癌症篩檢)
  • 市場參與企業
  • 市場分析

第3章 企業簡介

  • ABBOTT LABORATORIES
  • ACCUBIOTECH CO, LTD.
  • ACON LABORATORIES, INC
  • ALERE INC
  • ALFA SCIENTIFIC DESIGNS, INC
  • ARTRON LABORATORIES INC.
  • ATLAS LINK BIOTECH CO., LTD
  • AUDIT DIAGNOSTICS
  • AUTOBIO DIAGNOSTICS CO., LTD
  • BECKMAN COULTER, INC
  • BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.
  • BINDING SITE GROUP LTD.
  • BIOCARE DIAGNOSTICS LTD.
  • BIOCHECK, INC
  • BIOMERICA
  • BIOMERIEUX SA
  • BIOSCIENCE (TIANJIN) DIAGNOSTIC TECHNOLOGY CO., LTD.
  • BOSON BIOTECH CO. LTD
  • CLARITY DIAGNOSTICS, LLC
  • CTK BIOTECH, INC.
  • DIALAB GMBH
  • DIAMETRA
  • DIASORIN S.P.A.
  • DIASOURCE IMMUNOASSAYS SA
  • DRG INTERNATIONAL, INC.
  • FUJIREBIO US, INC.
  • GLYSBY SNC
  • GOLD STANDARD DIAGNOSTICS
  • LIFESIGN, LLC
  • MONOBIND, INC
  • NOVATEC IMMUNODIAGNOSTICA GMBH
  • OPERON
  • ORASURE TECHNOLOGIES, INC.
  • ORTHO CLINICAL DIAGNOSTICS
  • POLYMEDCO, INC
  • QUALIGEN, INC.
  • RANDOX LABORATORIES LTD.
  • ROCHE DIAGNOSTIC CORPORATION
  • SIEMENS HEALTHINEERS
  • SYNTRON BIORESEARCH, INC.
  • TECO DIAGNOSTICS
  • THERMO FISHER SCIENTIFIC, INC
  • Tosoh Bioscience
  • TRINITY BIOTECH PLC
  • WAKO DIAGNOSTICS
  • WAMA DIAGNOSTICA
目錄
Product Code: KLI15566365

Immunoassays have played a role in cancer management since the 1960s with the discovery of tumor markers alpha-fetoprotein (AFP) and carcinoembryonic antigen (CEA). These two tests are still an essential part of the cancer diagnostics toolbox.

Tumor Markers Immunoassay Market provides analysis of the current global market, including the following data points:

  • Tumor Markers Immunoassay Market by Marker, 2015-2025 (PSA, CEA, CA 125, AFP, CA 15-3, CA 19-9, CYFRA 21-1, ProGRP, SCC, CA 72-4, HE4, Others, Total)
  • Tumor Markers Immunoassay Market by Region, 2015-2025 (US, EU, ROW, Total)
  • Selected Tumor Marker Immunoassays
  • Attributes of Selected Tumor Marker Immunoassays (Cancer type, Tissue analyzed, How used)
  • Selected Companies Marketing Immunoassays for Tumor Markers

Biomarkers are biological or biochemical molecules, or genetic changes, or other characteristics that can be measured, and that indicate or predict a condition, risk, or likely response. Biomarkers can be used for a range of diagnostic applications including predicting disease risk, diagnosis, predicting prognosis, identifying appropriate therapy for an individual, monitoring disease or for return of a disease, and other applications. Much of the activity in the development and use of new biomarkers is in the field of oncology, where both single biomarkers and also biomarker panels are being developed and used for a wide range of applications - assessing risk of developing cancer, screening apparently healthy individuals for cancer, diagnosis of cancer, predicting prognosis, monitoring patients including monitoring for recurrence of disease, and determining the best therapy for treatment of a patient.

For many years, diagnostic assays for cancer have had important roles in diagnosis, determining prognosis, and monitoring of cancer. Early tests for diagnosis, determine prognosis, and monitoring patients with cancer include immunoassays for tumor markers originally developed by Centocor. Fujirebio acquired Centocor Diagnostics in 1998, and Centocor Diagnostics is now called Fujirebio Diagnostics.

Researchers are continuing to try to identify and validate new tumor biomarkers, but this has proven to be a slow process. Still, biomarker assays are being developed and added to the menus of large analyzers.

Assays for these tumor markers are still widely marketed by a large number of companies. Many of these companies are profiled in Tumor Markers Immunoassay Market, including:

  • Abbott Laboratories
  • AccuBioTech Co., Ltd
  • ACON Laboratories, Inc
  • Alere, Inc
  • Alfa Scientific Designs, Inc
  • Artron Laboratories, Inc
  • Atlas Link Biotech Co., Ltd
  • Audit Diagnostics
  • Autobio Diagnostics, Co., Ltd
  • Beckman Coulter, Inc
  • Beijing Wantai Biological Pharmacy Enterprise Co., Ltd
  • Binding Site Group Ltd
  • Biocare Diagnostics Ltd
  • Biocheck, Inc
  • Biomerica
  • bioMerieux SA
  • Bioscience (Tianjin) Diagnostic Technology Co., Ltd
  • Boson Biotech Co., Ltd
  • Clarity Diagnostics, LLC
  • CTK Biotech, Inc
  • DIALAB GmbH
  • Diametra
  • DiaSorin S.p.A
  • DIAsource ImmunoAssays SA
  • DRG International, Inc
  • Fujirebio US, Inc
  • GlysBy snc
  • Gold Standard Diagnostics
  • LifeSign, LLC
  • Monobind, Inc
  • Novatec Immunodiagnostica GmbH
  • Operon
  • OraSure Technologies, Inc
  • Ortho Clinical Diagnostics
  • Polymedco, Inc
  • Qualigen, Inc
  • Randox Laboratories, Ltd
  • Roche Diagnostic Corporation
  • Siemens Healthineers
  • Syntron Bioresearch, Inc
  • Teco Diagnostics
  • Thermo Fisher Scientific, Inc
  • Tosoh Bioscience, Inc
  • Trinity Biotech plc
  • Wako Diagnostics
  • WAMA Diagnostica

Table of Contents

1: EXECUTIVE SUMMARY

OVERVIEW

  • Table 1-1: Selected Widely Used Tumor Markers

CONCLUSIONS

  • The Current Global Market
  • The Tumor Markers Market Is at the Same Time Impressive and Distressing
  • Researchers Are Continuing to Try to Identify and Validate New Tumor Biomarkers

2: TUMOR MARKERS IMMUNOASSAY MARKET: ANALYSIS

TUMOR MARKERS

  • Table 2-1: Selected Tumor Marker Immunoassays
  • Table 2-2: Attributes of Selected Tumor Marker Immunoassays (Cancer type, Tissue analyzed, How used) .. 6
  • AFP (alfa-fetoprotein)
  • Beta HCG
  • CA 125
  • CA 15-3
  • CA 19-9
  • CEA (carcinoembryonic antigen)
  • CYFRA 21-1
  • HE4 (human epididymis protein 4)
  • ProGRP
  • PSA (complexed, free, total))
  • SCC (squamous cell carcinoma antigen)
  • Serum HER-2/neu
  • Thyroglobulin
  • CA 72-4

COMPANIES IN THE MARKET

  • Table 2-3: Selected Companies Marketing Immunoassays for Tumor Markers

MARKET ANALYSIS

  • Table 2-4: Tumor Markers Immunoassay Market by Marker, 2015-2025 ($ millions) (PSA, CEA, CA 125, AFP, CA 15-3, CA 19-9, CYFRA 21-1, ProGRP, SCC, CA 72-4, HE4, Others, Total)
  • Table 2-5: Tumor Markers Immunoassay Market by Region, 2015-2025 ($ millions) (US, EU, ROW, Total) . 17

3: COMPANY PROFILES

ABBOTT LABORATORIES

  • Table 3-1: Abbott Corporate Summary
  • Company Overview
  • Product
  • Company Financials
    • Table 3-2: Abbott Laboratories Revenue (2013-2016) ($ millions)

ACCUBIOTECH CO, LTD.

  • Table 3-3: AccuBioTech Summary
  • Company Overview
  • Products

ACON LABORATORIES, INC

  • Table 3-4: ACON Laboratories Corporate Summary
  • Company Overview
  • Products

ALERE INC

  • Table 3-5: Alere Corporate Summary
  • Company Overview
  • Product
  • Company Financials
    • Table 3-6: Alere Revenue (2013-2016) ($ millions)

ALFA SCIENTIFIC DESIGNS, INC

  • Table 3-7: Alfa Scientific Designs Summary
  • Company Overview
  • Products

ARTRON LABORATORIES INC.

  • Table 3-8: Artron Laboratories Corporate Summary
  • Company Overview
  • Products

ATLAS LINK BIOTECH CO., LTD

  • Table 3-9: Atlas Link Biotech Summary
  • Company Overview
  • Products

AUDIT DIAGNOSTICS

  • Table 3-10: Audit Diagnostics Corporate Summary
  • Company Overview
  • Products

AUTOBIO DIAGNOSTICS CO., LTD

  • Table 3-11: Autobio Diagnostics Summary
  • Company Overview
  • Products

BECKMAN COULTER, INC

  • Table 3-12: Beckman Coulter Corporate Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 3-13: Beckman Coulter (2013-2016) ($ millions)

BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.

  • Table 3-14: Beijing Wantai Biological Pharmacy Enterprise Corporate Summary
  • Company Overview
  • Products

BINDING SITE GROUP LTD.

  • Table 3-15: Binding Site Group Corporate Summary
  • Company Overview
  • Products

BIOCARE DIAGNOSTICS LTD.

  • Table 3-16: Biocare Diagnostics Corporate Summary
  • Company Overview
  • Productsi

BIOCHECK, INC

  • Table 3-17: Biocheck Corporate Summary
  • Company Overview
  • Products

BIOMERICA

  • Table 3-18: Biomerica Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 3-19: Biomerica (2013-2016) ($ millions)

BIOMERIEUX SA

  • Table 3-20: bioMerieux SA Corporate Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 3-21: bioMerieux Revenues (2013-2016) ($ millions)

BIOSCIENCE (TIANJIN) DIAGNOSTIC TECHNOLOGY CO., LTD.

  • Table 3-22: Bioscience (Tianjin) Diagnostic Technology Corporate Summary
  • Company Overview
  • Products

BOSON BIOTECH CO. LTD

  • Table 3-23: Boson Biotech Summary
  • Company Overview
  • Products

CLARITY DIAGNOSTICS, LLC

  • Table 3-24: Clarity Diagnostics Corporate Summary
  • Company Overview
  • Products

CTK BIOTECH, INC.

  • Table 3-25: CTK Biotech Corporate Summary
  • Company Overview
  • Products

DIALAB GMBH

  • Table 3-26: DIALAB Summary
  • Company Overview
  • Products

DIAMETRA

  • Table 3-27: Diametra Corporate Summary
  • Company Overview
  • Products

DIASORIN S.P.A.

  • Table 3-28: DiaSorin Corporate Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 3-29: DiaSorin (2013-2016) ($ millions)

DIASOURCE IMMUNOASSAYS SA

  • Table 3-30: DIAsource ImmunoAssays Corporate Summary
  • Company Overview
  • Products

DRG INTERNATIONAL, INC.

  • Table 3-31: DRG International Corporate Summary
  • Company Overview
  • Products

FUJIREBIO US, INC.

  • Table 3-32: Fujirebio Corporate Summary
  • Company Overview
  • Products

GLYSBY SNC

  • Table 3-33: GlysBy Corporate Summary
  • Company Overview
  • Products

GOLD STANDARD DIAGNOSTICS

  • Table 3-34: Gold Standard Diagnostics Corporate Summary
  • Company Overview
  • Products

LIFESIGN, LLC

  • Table 3-35: LifeSign Summary
  • Company Overview

MONOBIND, INC

  • Table 3-36: Monobind Corporate Summary
  • Company Overview
  • Products

NOVATEC IMMUNODIAGNOSTICA GMBH

  • Table 3-37: Novatec Immunodiagnostica Corporate Summary
  • Company Overview
  • Products

OPERON

  • Table 3-38: Operon Corporate Summary
  • Company Overview
  • Products

ORASURE TECHNOLOGIES, INC.

  • Table 3-39: OraSure Technologies Corporate Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 3-40: OraSure Revenue (2013-2016) ($ millions)

ORTHO CLINICAL DIAGNOSTICS

  • Table 3-41: Ortho Clinical Diagnostics Corporate Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 3-42: Ortho Clinical Diagnostics Revenue (2013-2016) ($ millions)

POLYMEDCO, INC

  • Table 3-43: Polymedco Corporate Summary
  • Company Overview
  • Products

QUALIGEN, INC.

  • Table 3-44: Qualigen Corporate Summary
  • Company Overview
  • Products

RANDOX LABORATORIES LTD.

  • Table 3-45: Randox Laboratories Corporate Summary
  • Company Overview
  • Products

ROCHE DIAGNOSTIC CORPORATION

  • Table 3-46: Roche Corporate Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 3-47: Roche Revenue (2013-2016) ($ millions)

SIEMENS HEALTHINEERS

  • Table 3-48: Siemens Healthineers Corporate Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 3-49: Siemens Healthineers Revenue (2013-2016) ($ millions)

SYNTRON BIORESEARCH, INC.

  • Table 3-50: Syntron Bioresearch Corporate Summary
  • Company Overview
  • Products

TECO DIAGNOSTICS

  • Table 3-51: Teco Diagnostics Corporate Summary
  • Company Overview
  • Products

THERMO FISHER SCIENTIFIC, INC

  • Table 3-52: Thermo Fisher Scientific Corporate Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 3-53: Thermo Fisher Scientific (2013-2016) ($ millions)

TOSOH BIOSCIENCE, INC.

  • Table 3-54: Tosoh Bioscience Corporate Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 3-55: Tosoh Corporation (2013-2016) ($ millions)

TRINITY BIOTECH PLC

  • Table 3-56: Trinity Biotech Corporate Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 3-57: Trinity Biotech Revenue (2013-2016) ($ millions)

WAKO DIAGNOSTICS

  • Wako Life Sciences
    • Table 3-58: Wako Diagnostics Corporate Summary
  • Company Overview
  • Products

WAMA DIAGNOSTICA

  • Table 3-59: WAMA Diagnostica Corporate Summary
  • Company Overview
  • Products
Back to Top